ClinicalTrials.Veeva

Menu

Intraductal Papillary Mucinous Neoplasm With Malignant Change

A

Asan Medical Center

Status

Terminated

Conditions

IPMN

Study type

Observational

Funder types

Other

Identifiers

NCT02044926
S2013-1472-0002

Details and patient eligibility

About

Purpose:

To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012.

Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.

Full description

  1. Purpose

    • To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012
  2. Enroll criteria

    • Patient who is suspected to have pancreas IPMN on imaging
    • Interval between imaging study and surgery is less than 2 months
    • Who is scheduled for surgery due to IPMN

Enrollment

54 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who is suspected to have IPMN by imaging study or clinician
  • Time interval between imaging study and surgery less than 2 months

Exclusion criteria

  • Patients who have pathology results not by surgery
  • Who is less than 20 years old
  • Who cannot voluntarily agree study design

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems